word,tfidf
inclusion,0.1802721746834233
criteria,0.16144612398164032
active,0.150977946297367
contraception,0.14968103192211815
disease,0.13520413101256745
history,0.13316776869608293
infection,0.13295072882902467
tuberculosis,0.13142724754137203
informed,0.1277764906652228
consent,0.12108459298623024
methods,0.11843363825683119
cell,0.11492351136068234
virus,0.11203181997267815
positive,0.10766755766917345
therapy,0.10590990262651119
intrauterine,0.10576778683435387
carcinoma,0.10563000168852511
immunodeficiency,0.10242909254644861
women,0.10242909254644861
pregnancy,0.10222119253217825
days,0.09689629389234002
upper,0.09602727426229557
heart,0.09585863611409895
hepatitis,0.09491967877987981
abstinence,0.09307565241423141
following,0.09238948952525443
human,0.09238948952525443
childbearing,0.09126892190373058
normal,0.09081344473967268
age,0.09066741698456711
use,0.08829084905245956
contraceptive,0.08396740815143212
participation,0.08396740815143212
donor,0.08337588079108327
weeks,0.08337588079108327
sexual,0.08038351799410894
pregnant,0.08031665127528291
limit,0.0765006330807285
18,0.0756778706163939
female,0.07301513752298447
potential,0.07210886987336931
systemic,0.07210886987336931
failure,0.07210886987336931
uncontrolled,0.07083391951919306
effective,0.07083391951919306
included,0.07063267924196763
min,0.0704200011256834
severe,0.06985546768982653
visit,0.06811008355475451
pulmonary,0.06800056273842534
creatinine,0.06800056273842534
insurance,0.06769138357398648
willing,0.06769138357398648
written,0.06721909198360689
vaccine,0.06571362377068601
device,0.06571362377068601
subject,0.06558748786754137
known,0.06516720595765761
oral,0.06516720595765761
status,0.06306489218032825
hypersensitivity,0.06206286689453679
past,0.06206286689453679
situ,0.06206286689453679
millimeter,0.06206286689453679
basal,0.06206286689453679
50,0.06084185895565536
serum,0.06054229649311512
bone,0.059500492396122165
child,0.05922996062723816
live,0.05922996062723816
10,0.058588456772112565
uveitis,0.058588456772112565
agent,0.05841211001838757
skin,0.05801970080590199
received,0.05801970080590199
hormonal,0.057616364557377335
transferase,0.057616364557377335
amino,0.057616364557377335
negative,0.05666713561535445
requiring,0.055497105118688855
marrow,0.055497105118688855
coverage,0.05499924915386401
cooperative,0.05476135314223835
york,0.05476135314223835
eastern,0.05476135314223835
eligible,0.054415455415300816
30,0.054081652405026985
test,0.054081652405026985
renal,0.053833778834586725
old,0.051214546273224304
alanine,0.051214546273224304
signed,0.051214546273224304
cervix,0.051110596266089124
mmhg,0.051110596266089124
nervous,0.051000422053818995
cubic,0.05076853768048986
curatorship,0.05076853768048986
group,0.0495748480379414
cardiac,0.0495748480379414
investigational,0.04816706527305128
aspartate,0.048013637131147785
oncology,0.048013637131147785
bilirubin,0.048013637131147785
central,0.047929318057049475
malignancy,0.047459839389939903
partner,0.047459839389939903
transplantation,0.04732144585439861
progestogen,0.046537826207115704
month,0.04540672236983634
performans,0.045333708492283555
clearance,0.045333708492283555
adequate,0.045333708492283555
aged,0.045333708492283555
involvement,0.045068043670855824
medical,0.045068043670855824
diagnosis,0.044812727989071266
insufficiency,0.043809082513790676
unable,0.043809082513790676
highly,0.043809082513790676
receiving,0.04288412668262321
milligrams,0.04281464148731303
association,0.04250035171151584
ecog,0.04250035171151584
vaccines,0.04230711473374155
hcv,0.04230711473374155
aminotransferase,0.04161181884699475
duration,0.04056123930377024
organ,0.04036153099541008
clinically,0.039666994930748115
ml,0.039666994930748115
male,0.03841090970491823
legal,0.03841090970491823
evidence,0.03830783712022745
stem,0.03830783712022745
health,0.03830783712022745
chronic,0.03830783712022745
security,0.038076403260367396
ius,0.038076403260367396
103,0.038076403260367396
previous,0.03783893530819695
breastfeeding,0.036507568761492235
treated,0.03605443493668466
intravenous,0.03605443493668466
count,0.03605443493668466
cancer,0.035316339620983815
function,0.035316339620983815
infectious,0.035316339620983815
deciliter,0.0352100005628417
psychiatric,0.0352100005628417
respiratory,0.03400028136921267
pressure,0.03400028136921267
hbsag,0.03384569178699324
injectable,0.03384569178699324
transdermal,0.03384569178699324
sterilization,0.03384569178699324
bearing,0.03384569178699324
12,0.03380103275314186
anti,0.03380103275314186
total,0.03380103275314186
acute,0.03380103275314186
squamous,0.03285681188534301
confirmed,0.032793743933770686
antigen,0.032793743933770686
usual,0.032793743933770686
significant,0.032793743933770686
ventricular,0.03200909142076518
breast,0.03200909142076518
medicinal,0.03200909142076518
considered,0.03154763056959907
transplant,0.03154763056959907
treatments,0.03154763056959907
presence,0.03027114824655756
cyclophosphamide,0.03027114824655756
investigator,0.03027114824655756
able,0.03027114824655756
absence,0.03027114824655756
performance,0.03027114824655756
antibody,0.03027114824655756
reproductive,0.02961498031361908
permitted,0.02961498031361908
30ml,0.02961498031361908
seropositivity,0.02961498031361908
available,0.029294228386056283
associated,0.029294228386056283
grade,0.029294228386056283
specific,0.029294228386056283
infusion,0.029294228386056283
hcg,0.029206055009193786
ray,0.029206055009193786
ovulation,0.029206055009193786
indication,0.029206055009193786
excipients,0.029206055009193786
checked,0.029206055009193786
interventional,0.028808182278688668
chest,0.028808182278688668
capacity,0.028808182278688668
social,0.028808182278688668
fraction,0.028808182278688668
planned,0.028808182278688668
meet,0.028333567807677224
combined,0.028333567807677224
hypertension,0.028333567807677224
immunosuppressive,0.028333567807677224
procedures,0.028333567807677224
detected,0.028333567807677224
matched,0.027748552559344428
selection,0.027748552559344428
baseline,0.027748552559344428
intensive,0.027748552559344428
current,0.027040826202513493
eye,0.027040826202513493
period,0.027040826202513493
syndrome,0.027040826202513493
150,0.025607273136612152
agents,0.025607273136612152
men,0.025607273136612152
fever,0.025607273136612152
leukemia,0.025607273136612152
ejection,0.025607273136612152
substance,0.025555298133044562
preferred,0.025555298133044562
urinary,0.025555298133044562
htlv,0.025555298133044562
lifestyle,0.025555298133044562
condom,0.025555298133044562
affiliated,0.025555298133044562
abnormalities,0.025555298133044562
rna,0.025555298133044562
feeding,0.025555298133044562
provide,0.025500211026909497
method,0.025500211026909497
product,0.025500211026909497
french,0.025500211026909497
lung,0.025500211026909497
currently,0.025500211026909497
methotrexate,0.02538426884024493
abuse,0.02538426884024493
contra,0.02538426884024493
barrier,0.02538426884024493
releasing,0.02538426884024493
recurrent,0.02538426884024493
unwilling,0.02538426884024493
tubal,0.02538426884024493
untreated,0.02538426884024493
intercourse,0.02538426884024493
obstruction,0.02538426884024493
intravaginal,0.02538426884024493
interfere,0.02538426884024493
ks,0.025225956872131302
laboratory,0.025225956872131302
eligibility,0.025225956872131302
major,0.025225956872131302
standardization,0.025225956872131302
leukocyte,0.025225956872131302
nomenclature,0.025225956872131302
care,0.0247874240189707
previously,0.0247874240189707
70,0.0247874240189707
hematopoietic,0.0247874240189707
cutaneous,0.02270336118491817
international,0.02270336118491817
covid,0.02270336118491817
symptoms,0.02270336118491817
iii,0.02270336118491817
prednisone,0.02270336118491817
antibodies,0.02270336118491817
mean,0.02270336118491817
screening,0.022666854246141777
receive,0.022666854246141777
disorders,0.022666854246141777
pcr,0.022666854246141777
chemotherapy,0.022666854246141777
protection,0.022666854246141777
left,0.022666854246141777
participants,0.022666854246141777
40,0.022534021835427912
20,0.022534021835427912
19,0.022534021835427912
posterior,0.022534021835427912
high,0.022534021835427912
60,0.022534021835427912
hemoglobin,0.022406363994535633
illness,0.022406363994535633
disorder,0.022406363994535633
diagnosed,0.022406363994535633
109,0.022406363994535633
equivalent,0.022406363994535633
administered,0.022406363994535633
exclusion,0.022406363994535633
participate,0.022406363994535633
cdai,0.021904541256895338
permanent,0.021904541256895338
allowed,0.021904541256895338
rituximab,0.021904541256895338
serology,0.021904541256895338
agree,0.021153557366870777
symptomatic,0.021153557366870777
oxaloacetictransferase,0.021153557366870777
debilitating,0.021153557366870777
guardianship,0.021153557366870777
glutamopyruvatetransferase,0.021153557366870777
glutamic,0.021153557366870777
artery,0.021153557366870777
fulfilling,0.021153557366870777
azathioprine,0.021153557366870777
2n,0.021153557366870777
condoms,0.021153557366870777
understanding,0.021153557366870777
tutorship,0.021153557366870777
recovered,0.021153557366870777
ag,0.021153557366870777
visceral,0.021153557366870777
administration,0.02028061965188512
signs,0.02028061965188512
follow,0.02028061965188512
obtained,0.02018076549770504
transfusion,0.02018076549770504
anemia,0.02018076549770504
type,0.02018076549770504
sclerosis,0.02018076549770504
acs,0.019833497465374057
donors,0.019833497465374057
mofetil,0.019833497465374057
values,0.019833497465374057
documented,0.019833497465374057
mycophenolate,0.019833497465374057
meeting,0.019833497465374057
arterial,0.019205454852459114
echocardiography,0.019205454852459114
orally,0.019205454852459114
inhibition,0.019205454852459114
definition,0.019205454852459114
birth,0.019205454852459114
attenuated,0.019205454852459114
drugs,0.019205454852459114
prevent,0.019205454852459114
products,0.019205454852459114
lesion,0.019205454852459114
medication,0.019205454852459114
contraindication,0.019205454852459114
inform,0.019205454852459114
monoclonal,0.019205454852459114
filtration,0.018253784380746117
1500,0.018253784380746117
prophylactic,0.018253784380746117
willingness,0.018253784380746117
monoxide,0.018253784380746117
smpc,0.018253784380746117
myocardial,0.018253784380746117
carbon,0.018253784380746117
periods,0.018253784380746117
biologic,0.018253784380746117
rest,0.018253784380746117
hbs,0.018253784380746117
harvest,0.018253784380746117
anaphylactic,0.018253784380746117
relation,0.018253784380746117
preinclusion,0.018253784380746117
reactions,0.018253784380746117
sodium,0.018253784380746117
steroid,0.01802721746834233
lesions,0.01802721746834233
adverse,0.01802721746834233
year,0.01802721746834233
complete,0.01802721746834233
right,0.017658169810491908
antibiotics,0.017658169810491908
hospitalization,0.017658169810491908
allogeneic,0.017658169810491908
belimumab,0.017658169810491908
imaging,0.017658169810491908
adult,0.017658169810491908
liver,0.017658169810491908
pan,0.017000140684606334
individuals,0.017000140684606334
recent,0.017000140684606334
general,0.017000140684606334
national,0.017000140684606334
corrected,0.017000140684606334
note,0.017000140684606334
initiation,0.017000140684606334
heterosexual,0.01692284589349662
hemorrhagic,0.01692284589349662
postero,0.01692284589349662
50ml,0.01692284589349662
vasectomised,0.01692284589349662
gfr,0.01692284589349662
vasectomy,0.01692284589349662
yellow,0.01692284589349662
guidance,0.01692284589349662
hbv,0.01692284589349662
hormone,0.01692284589349662
hg,0.01692284589349662
cystitis,0.01692284589349662
implantable,0.01692284589349662
correctly,0.01692284589349662
infarction,0.01692284589349662
parents,0.01692284589349662
affiliation,0.01692284589349662
inadequate,0.01692284589349662
consistently,0.01692284589349662
lateral,0.01692284589349662
congestive,0.01692284589349662
children,0.01692284589349662
mfi,0.01692284589349662
consolidation,0.01692284589349662
lives,0.01692284589349662
lymphoblastic,0.01692284589349662
evolving,0.01692284589349662
condition,0.01600454571038259
comply,0.01600454571038259
interferon,0.01600454571038259
cervical,0.01600454571038259
idiopathic,0.01600454571038259
unless,0.01600454571038259
glomerular,0.01600454571038259
28,0.01600454571038259
hepatic,0.01600454571038259
radiotherapy,0.01600454571038259
bilateral,0.01600454571038259
measures,0.015773815284799535
randomization,0.015773815284799535
sars,0.015773815284799535
response,0.015773815284799535
rate,0.015773815284799535
anterior,0.015773815284799535
unit,0.015773815284799535
tumor,0.01513557412327878
sle,0.01513557412327878
platelet,0.01513557412327878
classification,0.01513557412327878
neutrophil,0.01513557412327878
surgery,0.01513557412327878
adalimumab,0.01513557412327878
100,0.01513557412327878
antibiotic,0.01513557412327878
identical,0.01513557412327878
corticosteroids,0.01513557412327878
mn,0.014603027504596893
isolated,0.014603027504596893
nursing,0.014603027504596893
occlusion,0.014603027504596893
myelofibrosis,0.014603027504596893
suggestive,0.014603027504596893
suspected,0.014603027504596893
92,0.014603027504596893
tract,0.014603027504596893
applicable,0.014603027504596893
antiviral,0.014603027504596893
progressive,0.014603027504596893
intestinal,0.014603027504596893
woman,0.014603027504596893
concurrent,0.014603027504596893
diffusing,0.014603027504596893
73m2,0.014603027504596893
ctfg,0.014603027504596893
stable,0.014603027504596893
75,0.014603027504596893
philadelphia,0.014603027504596893
allergic,0.014603027504596893
demyelinating,0.014603027504596893
quantiferon,0.014603027504596893
section,0.014166783903838612
talimogene,0.014166783903838612
absolute,0.014166783903838612
laherparepvec,0.014166783903838612
injections,0.014166783903838612
stopping,0.014166783903838612
needs,0.014166783903838612
white,0.014166783903838612
35,0.014166783903838612
autoimmune,0.014166783903838612
replacement,0.014166783903838612
steroids,0.013520413101256746
life,0.013520413101256746
kilograms,0.013520413101256746
management,0.013520413101256746
vasculitis,0.013520413101256746
oxygen,0.012803636568306076
diabetes,0.012803636568306076
prescribed,0.012803636568306076
ct,0.012803636568306076
immunosuppressant,0.012803636568306076
atrial,0.012803636568306076
urine,0.012803636568306076
times,0.012803636568306076
excluded,0.012803636568306076
authorized,0.012803636568306076
half,0.012803636568306076
forced,0.012803636568306076
scd,0.012803636568306076
metastatic,0.012803636568306076
neutropenia,0.012803636568306076
colon,0.012803636568306076
nb,0.012803636568306076
insulin,0.012692134420122465
contraindications,0.012692134420122465
lipase,0.012692134420122465
ipss,0.012692134420122465
consisting,0.012692134420122465
intravitreal,0.012692134420122465
explorations,0.012692134420122465
exceptions,0.012692134420122465
man,0.012692134420122465
systolic,0.012692134420122465
nilotinib,0.012692134420122465
abscess,0.012692134420122465
catheterization,0.012692134420122465
coronary,0.012692134420122465
contraceptives,0.012692134420122465
mol,0.012692134420122465
electrocardiogram,0.012692134420122465
mellitus,0.012692134420122465
macrophages,0.012692134420122465
cmu,0.012692134420122465
lymphopenia,0.012692134420122465
estrogen,0.012692134420122465
vitiligo,0.012692134420122465
vaginal,0.012692134420122465
vaccination,0.012692134420122465
ring,0.012692134420122465
foam,0.012692134420122465
finished,0.012692134420122465
unwillingness,0.012692134420122465
azoospermia,0.012692134420122465
sexually,0.012692134420122465
proteins,0.012692134420122465
psoriasis,0.012692134420122465
5xuln,0.012692134420122465
solid,0.012692134420122465
conceive,0.012692134420122465
salt,0.012692134420122465
refraining,0.012692134420122465
psychological,0.012692134420122465
progressing,0.012692134420122465
hypothyroidism,0.012692134420122465
hemopathy,0.012692134420122465
her2,0.012692134420122465
resting,0.012692134420122465
universal,0.012692134420122465
histologically,0.012692134420122465
pneumonia,0.012692134420122465
potassium,0.012692134420122465
preclude,0.012692134420122465
advance,0.012692134420122465
alcohol,0.012692134420122465
starch,0.012692134420122465
aiec,0.012612978436065651
body,0.012612978436065651
80,0.012612978436065651
specified,0.012612978436065651
threatening,0.012612978436065651
completed,0.012612978436065651
cov2,0.012612978436065651
bd,0.012612978436065651
required,0.012612978436065651
need,0.012612978436065651
evaluated,0.012612978436065651
visits,0.012612978436065651
scale,0.012612978436065651
cd,0.011333427123070889
enrolled,0.011333427123070889
magnetic,0.011333427123070889
vital,0.011333427123070889
causes,0.011333427123070889
malignant,0.011333427123070889
intermediate,0.011333427123070889
prophylaxis,0.011333427123070889
biological,0.011333427123070889
hours,0.011333427123070889
infliximab,0.011333427123070889
initial,0.011333427123070889
treosulfan,0.011333427123070889
voc,0.011333427123070889
sibling,0.011333427123070889
american,0.011333427123070889
graall,0.011333427123070889
discontinuation,0.011333427123070889
reasons,0.011333427123070889
formula,0.011333427123070889
recipient,0.011333427123070889
respectively,0.011333427123070889
resonance,0.011333427123070889
peripheral,0.011267010917713956
secondary,0.011267010917713956
red,0.011267010917713956
assessment,0.011267010917713956
ii,0.011267010917713956
procedure,0.011267010917713956
events,0.011267010917713956
corticosteroid,0.011267010917713956
cells,0.011267010917713956
injection,0.011267010917713956
containing,0.010952270628447669
older,0.010952270628447669
neoplasm,0.010952270628447669
neuropathy,0.010952270628447669
achieve,0.010952270628447669
takes,0.010952270628447669
emergency,0.010952270628447669
entering,0.010952270628447669
entire,0.010952270628447669
compatible,0.010952270628447669
excluding,0.010952270628447669
father,0.010952270628447669
karyotype,0.010952270628447669
congenital,0.010952270628447669
masquerade,0.010952270628447669
latent,0.010952270628447669
topical,0.010952270628447669
transaminases,0.010952270628447669
mentioned,0.010952270628447669
consistent,0.010952270628447669
findings,0.010952270628447669
applies,0.010952270628447669
reliability,0.010952270628447669
regulations,0.010952270628447669
ileum,0.010952270628447669
haplotype,0.010952270628447669
diameter,0.010952270628447669
diaphragm,0.010952270628447669
understand,0.010952270628447669
pneumonitis,0.010952270628447669
influenza,0.010952270628447669
spot,0.010952270628447669
bolus,0.010952270628447669
igra,0.010952270628447669
dependence,0.010952270628447669
hydroxyurea,0.010952270628447669
requires,0.010952270628447669
ensure,0.01009038274885252
viral,0.01009038274885252
25,0.01009038274885252
thrombosis,0.01009038274885252
week,0.01009038274885252
therapies,0.01009038274885252
long,0.01009038274885252
course,0.01009038274885252
ileal,0.01009038274885252
stage,0.01009038274885252
inhibitor,0.01009038274885252
randomized,0.01009038274885252
recommended,0.01009038274885252
frequency,0.01009038274885252
vascular,0.01009038274885252
base,0.009602727426229557
physician,0.009602727426229557
assay,0.009602727426229557
range,0.009602727426229557
preexisting,0.009602727426229557
efficient,0.009602727426229557
reaction,0.009602727426229557
fluid,0.009602727426229557
segment,0.009602727426229557
scan,0.009602727426229557
rodnan,0.009602727426229557
newly,0.009602727426229557
rheumatology,0.009602727426229557
doppler,0.009602727426229557
acquired,0.009602727426229557
accordance,0.009602727426229557
acceptable,0.009602727426229557
stenosis,0.009602727426229557
college,0.009602727426229557
cohort,0.009602727426229557
cyclosporine,0.009602727426229557
documentation,0.009602727426229557
120,0.009602727426229557
abnormal,0.009602727426229557
tissue,0.009602727426229557
haploidentical,0.009602727426229557
gold,0.009602727426229557
immunotherapy,0.009602727426229557
inactive,0.009602727426229557
minor,0.009602727426229557
minimum,0.009602727426229557
state,0.009602727426229557
validated,0.009013608734171164
levels,0.009013608734171164
cryoglobulinemia,0.009013608734171164
severity,0.009013608734171164
multiple,0.009013608734171164
post,0.009013608734171164
retinal,0.009013608734171164
placebo,0.009013608734171164
assessed,0.009013608734171164
primary,0.009013608734171164
progression,0.009013608734171164
relapse,0.009013608734171164
recommendations,0.009013608734171164
end,0.009013608734171164
activity,0.009013608734171164
optimal,0.009013608734171164
taking,0.008500070342303167
surface,0.008500070342303167
context,0.008500070342303167
institute,0.008500070342303167
gamma,0.008500070342303167
involving,0.008500070342303167
22,0.008500070342303167
endemic,0.008500070342303167
weight,0.008500070342303167
discontinued,0.008500070342303167
2008,0.008500070342303167
determined,0.008500070342303167
table,0.008500070342303167
measured,0.008500070342303167
aml,0.008500070342303167
aplastic,0.008500070342303167
extra,0.008500070342303167
moderate,0.008500070342303167
publique,0.008500070342303167
biopsy,0.008500070342303167
acuity,0.008500070342303167
pharmacodynamic,0.008500070342303167
regimen,0.008500070342303167
examination,0.008500070342303167
repeated,0.008500070342303167
belonging,0.00846142294674831
bladder,0.00846142294674831
blast,0.00846142294674831
predicted,0.00846142294674831
pao2,0.00846142294674831
patch,0.00846142294674831
capable,0.00846142294674831
parenteral,0.00846142294674831
arrhythmia,0.00846142294674831
recombinant,0.00846142294674831
realization,0.00846142294674831
explained,0.00846142294674831
percutaneous,0.00846142294674831
vedolizumab,0.00846142294674831
positivity,0.00846142294674831
precludes,0.00846142294674831
physiologic,0.00846142294674831
authorizing,0.00846142294674831
pituitary,0.00846142294674831
reactivation,0.00846142294674831
vena,0.00846142294674831
epilepsy,0.00846142294674831
bacillus,0.00846142294674831
auxiliary,0.00846142294674831
pressures,0.00846142294674831
mydriasis,0.00846142294674831
myelodysplasia,0.00846142294674831
excised,0.00846142294674831
cava,0.00846142294674831
sale,0.00846142294674831
expecting,0.00846142294674831
rhythm,0.00846142294674831
3n,0.00846142294674831
uveitic,0.00846142294674831
catheter,0.00846142294674831
rf,0.00846142294674831
ligation,0.00846142294674831
completely,0.00846142294674831
adrenal,0.00846142294674831
aid,0.00846142294674831
colloidal,0.00846142294674831
allergy,0.00846142294674831
alkylating,0.00846142294674831
dsa,0.00846142294674831
measurable,0.00846142294674831
chromosome,0.00846142294674831
450,0.00846142294674831
amenable,0.00846142294674831
amylase,0.00846142294674831
microcrystalline,0.00846142294674831
silica,0.00846142294674831
cluster,0.00846142294674831
monocular,0.00846142294674831
modifying,0.00846142294674831
chlorambucil,0.00846142294674831
chloride,0.00846142294674831
altered,0.00846142294674831
scanner,0.00846142294674831
anhydrous,0.00846142294674831
cellulose,0.00846142294674831
ustekinumab,0.00846142294674831
uropathogen,0.00846142294674831
necessitating,0.00846142294674831
septic,0.00846142294674831
morphologic,0.00846142294674831
muscle,0.00846142294674831
cooperation,0.00846142294674831
suicide,0.00846142294674831
thrombopenia,0.00846142294674831
undergone,0.00846142294674831
geno,0.00846142294674831
court,0.00846142294674831
interstitial,0.00846142294674831
suicidal,0.00846142294674831
conjunction,0.00846142294674831
substrate,0.00846142294674831
largest,0.00846142294674831
lactation,0.00846142294674831
ischemic,0.00846142294674831
irradiated,0.00846142294674831
jelly,0.00846142294674831
instructions,0.00846142294674831
intermittent,0.00846142294674831
iga,0.00846142294674831
herpetic,0.00846142294674831
hypromellose,0.00846142294674831
hydrochloride,0.00846142294674831
titanium,0.00846142294674831
thyroxine,0.00846142294674831
cytolysis,0.00846142294674831
implants,0.00846142294674831
icbd,0.00846142294674831
washout,0.00846142294674831
disodium,0.00846142294674831
5n,0.00846142294674831
dioxide,0.00846142294674831
hb,0.00846142294674831
hbcab,0.00846142294674831
1st,0.00846142294674831
10mm,0.00846142294674831
visual,0.00756778706163939
biopsies,0.00756778706163939
radiation,0.00756778706163939
ratio,0.00756778706163939
place,0.00756778706163939
tocilizumab,0.00756778706163939
calculated,0.00756778706163939
release,0.00756778706163939
appendix,0.00756778706163939
transfusions,0.00756778706163939
cycles,0.00756778706163939
score,0.00756778706163939
neurological,0.00756778706163939
inflammatory,0.00756778706163939
limited,0.00756778706163939
double,0.00756778706163939
syndromes,0.00756778706163939
2014,0.00756778706163939
17,0.00756778706163939
16,0.00756778706163939
11,0.00756778706163939
45,0.00756778706163939
index,0.00756778706163939
projected,0.0073015137522984466
72,0.0073015137522984466
partners,0.0073015137522984466
prothrombin,0.0073015137522984466
bacterial,0.0073015137522984466
distinct,0.0073015137522984466
365,0.0073015137522984466
deficiency,0.0073015137522984466
anticipated,0.0073015137522984466
sepsis,0.0073015137522984466
segmental,0.0073015137522984466
igg,0.0073015137522984466
monthly,0.0073015137522984466
cerebro,0.0073015137522984466
coli,0.0073015137522984466
undergo,0.0073015137522984466
curative,0.0073015137522984466
small,0.0073015137522984466
signing,0.0073015137522984466
clonal,0.0073015137522984466
sickle,0.0073015137522984466
shock,0.0073015137522984466
rheumatism,0.0073015137522984466
existing,0.0073015137522984466
cdeis,0.0073015137522984466
phosphate,0.0073015137522984466
hospitalized,0.0073015137522984466
cap,0.0073015137522984466
effusion,0.0073015137522984466
budesonide,0.0073015137522984466
verified,0.0073015137522984466
components,0.0073015137522984466
cream,0.0073015137522984466
lineage,0.0073015137522984466
sponge,0.0073015137522984466
laws,0.0073015137522984466
spinal,0.0073015137522984466
globulin,0.0073015137522984466
thoracic,0.0073015137522984466
culture,0.0073015137522984466
sperm,0.0073015137522984466
tyrosine,0.0073015137522984466
flu,0.0073015137522984466
magnesium,0.0073015137522984466
league,0.0073015137522984466
suffering,0.0073015137522984466
encephalitis,0.0073015137522984466
vessels,0.0073015137522984466
kinase,0.0073015137522984466
country,0.0073015137522984466
donnees,0.0073015137522984466
withdrawn,0.0073015137522984466
subcutaneous,0.0073015137522984466
lethargy,0.0073015137522984466
fibrosis,0.0073015137522984466
edge,0.0073015137522984466
cytogenetic,0.0073015137522984466
field,0.0073015137522984466
linked,0.0073015137522984466
modified,0.006760206550628373
rates,0.006760206550628373
macular,0.006760206550628373
conditioning,0.006760206550628373
complications,0.006760206550628373
unrelated,0.006760206550628373
doses,0.006760206550628373
increase,0.006760206550628373
greater,0.006760206550628373
haplo,0.006760206550628373
sensitivity,0.006760206550628373
value,0.006760206550628373
pre,0.006760206550628373
best,0.006760206550628373
behcets,0.006760206550628373
capmatinib,0.006760206550628373
plus,0.006401818284153038
strong,0.006401818284153038
dosage,0.006401818284153038
compliance,0.006401818284153038
advanced,0.006401818284153038
agreed,0.006401818284153038
lymphoma,0.006401818284153038
chorioretinal,0.006401818284153038
marker,0.006401818284153038
brochure,0.006401818284153038
approved,0.006401818284153038
block,0.006401818284153038
hsv,0.006401818284153038
proven,0.006401818284153038
discretion,0.006401818284153038
whichever,0.006401818284153038
enrollment,0.006401818284153038
prescription,0.006401818284153038
prevention,0.006401818284153038
prednisolone,0.006401818284153038
digestive,0.006401818284153038
persistent,0.006401818284153038
records,0.006401818284153038
despite,0.006401818284153038
thymocyte,0.006401818284153038
requirements,0.006401818284153038
pediatric,0.006401818284153038
bacteria,0.006401818284153038
intolerance,0.006401818284153038
sustained,0.006401818284153038
volume,0.006401818284153038
invasive,0.006401818284153038
label,0.006401818284153038
lack,0.006401818284153038
intravenously,0.006401818284153038
european,0.006401818284153038
conduct,0.006401818284153038
admission,0.006401818284153038
conditions,0.006401818284153038
maintain,0.006401818284153038
sign,0.006401818284153038
controlled,0.006401818284153038
400,0.006401818284153038
molecular,0.006401818284153038
immunization,0.006401818284153038
ms,0.006401818284153038
immunosuppressants,0.006401818284153038
nephropathy,0.006401818284153038
outside,0.006401818284153038
immunosuppression,0.006401818284153038
59,0.006401818284153038
mild,0.006401818284153038
shall,0.006401818284153038
microalbuminuria,0.006401818284153038
thrombocytopenia,0.006401818284153038
mass,0.006401818284153038
induction,0.006401818284153038
initiated,0.006401818284153038
ventilation,0.005666713561535444
abo,0.005666713561535444
95,0.005666713561535444
identification,0.005666713561535444
identified,0.005666713561535444
pathology,0.005666713561535444
hydrogen,0.005666713561535444
hematological,0.005666713561535444
hemolytic,0.005666713561535444
dna,0.005666713561535444
provided,0.005666713561535444
enrolment,0.005666713561535444
entry,0.005666713561535444
potentially,0.005666713561535444
objective,0.005666713561535444
300,0.005666713561535444
grafalon,0.005666713561535444
infarct,0.005666713561535444
underlying,0.005666713561535444
ebv,0.005666713561535444
choice,0.005666713561535444
chosen,0.005666713561535444
500,0.005666713561535444
modification,0.005666713561535444
mmol,0.005666713561535444
demonstrate,0.005666713561535444
fludarabine,0.005666713561535444
common,0.005666713561535444
fish,0.005666713561535444
cov,0.005666713561535444
continue,0.005666713561535444
ion,0.005666713561535444
judgment,0.005666713561535444
present,0.00504519137442626
haze,0.00504519137442626
presented,0.00504519137442626
refer,0.00504519137442626
residual,0.00504519137442626
withdrawal,0.00504519137442626
concomitant,0.00504519137442626
start,0.00504519137442626
measure,0.00504519137442626
classic,0.00504519137442626
testing,0.00504519137442626
48,0.00504519137442626
sct,0.00504519137442626
good,0.00504519137442626
investigators,0.00504519137442626
opinion,0.00504519137442626
inflammation,0.00504519137442626
spartalizumab,0.00504519137442626
manifestations,0.00504519137442626
remission,0.004506804367085582
resolution,0.004506804367085582
ocular,0.004506804367085582
versus,0.004506804367085582
poor,0.004506804367085582
vessel,0.004506804367085582
benefit,0.004506804367085582
evolution,0.004506804367085582
arm,0.004506804367085582
host,0.004506804367085582
refractory,0.004506804367085582
death,0.004506804367085582
decision,0.004506804367085582
chimerism,0.004506804367085582
early,0.004506804367085582
daily,0.004506804367085582
edema,0.004506804367085582
55,0.004506804367085582
groups,0.004506804367085582
graft,0.004506804367085582
second,0.004506804367085582
increased,0.004506804367085582
met,0.004506804367085582
collection,0.004506804367085582
interval,0.004506804367085582
level,0.004506804367085582
concentration,0.004506804367085582
additional,0.004506804367085582
vitreous,0.004506804367085582
vi,0.004230711473374155
viii,0.004230711473374155
11q23,0.004230711473374155
12p,0.004230711473374155
131,0.004230711473374155
17q,0.004230711473374155
qualify,0.004230711473374155
pyuria,0.004230711473374155
pumonary,0.004230711473374155
suspicion,0.004230711473374155
supra,0.004230711473374155
suppressive,0.004230711473374155
judgement,0.004230711473374155
join,0.004230711473374155
ionizing,0.004230711473374155
involuntary,0.004230711473374155
language,0.004230711473374155
lactating,0.004230711473374155
draining,0.004230711473374155
pregelatinized,0.004230711473374155
preferable,0.004230711473374155
prohibit,0.004230711473374155
couverture,0.004230711473374155
cousin,0.004230711473374155
intramuscular,0.004230711473374155
universite,0.004230711473374155
universelle,0.004230711473374155
killed,0.004230711473374155
suppress,0.004230711473374155
suppository,0.004230711473374155
b19,0.004230711473374155
av,0.004230711473374155
autologous,0.004230711473374155
prostatic,0.004230711473374155
propylene,0.004230711473374155
xanthine,0.004230711473374155
104,0.004230711473374155
worldwide,0.004230711473374155
liters,0.004230711473374155
linguistic,0.004230711473374155
concurrently,0.004230711473374155
administrative,0.004230711473374155
acyclovir,0.004230711473374155
sterility,0.004230711473374155
limb,0.004230711473374155
li,0.004230711473374155
talc,0.004230711473374155
acetate,0.004230711473374155
t38c,0.004230711473374155
inserm,0.004230711473374155
crisis,0.004230711473374155
creatininemia,0.004230711473374155
cr1,0.004230711473374155
covered,0.004230711473374155
glycerol,0.004230711473374155
glass,0.004230711473374155
gilz,0.004230711473374155
generally,0.004230711473374155
gave,0.004230711473374155
fungals,0.004230711473374155
ctla4,0.004230711473374155
couple,0.004230711473374155
inr,0.004230711473374155
injectables,0.004230711473374155
levonorgestrel,0.004230711473374155
leukoencephalopathy,0.004230711473374155
leucocytes,0.004230711473374155
leucocyte,0.004230711473374155
leflunomide,0.004230711473374155
lbs,0.004230711473374155
agonists,0.004230711473374155
society,0.004230711473374155
smp,0.004230711473374155
smd,0.004230711473374155
maladie,0.004230711473374155
maize,0.004230711473374155
complex,0.004230711473374155
community,0.004230711473374155
complicated,0.004230711473374155
stents,0.004230711473374155
stearyl,0.004230711473374155
stearate,0.004230711473374155
srs2,0.004230711473374155
spermicidal,0.004230711473374155
umr,0.004230711473374155
glycol,0.004230711473374155
dysgueusia,0.004230711473374155
formal,0.004230711473374155
flutter,0.004230711473374155
fluoropyrimidine,0.004230711473374155
fistulas,0.004230711473374155
fistula,0.004230711473374155
infants,0.004230711473374155
ineligible,0.004230711473374155
indwelling,0.004230711473374155
incomplete,0.004230711473374155
incarcerated,0.004230711473374155
crospovidone,0.004230711473374155
infected,0.004230711473374155
madrs,0.004230711473374155
macrogol,0.004230711473374155
locally,0.004230711473374155
donating,0.004230711473374155
fraumeni,0.004230711473374155
fralle,0.004230711473374155
unresolved,0.004230711473374155
unresectable,0.004230711473374155
marfan,0.004230711473374155
mapping,0.004230711473374155
mannitol,0.004230711473374155
algorithm,0.004230711473374155
albumin,0.004230711473374155
sister,0.004230711473374155
meningoencephalitis,0.004230711473374155
cocktail,0.004230711473374155
singer,0.004230711473374155
e172,0.004230711473374155
e171,0.004230711473374155
unfit,0.004230711473374155
fio2,0.004230711473374155
duct,0.004230711473374155
dual,0.004230711473374155
mdw,0.004230711473374155
sucrose,0.004230711473374155
subtenons,0.004230711473374155
latex,0.004230711473374155
connective,0.004230711473374155
conjugated,0.004230711473374155
confound,0.004230711473374155
confined,0.004230711473374155
conduction,0.004230711473374155
steroidal,0.004230711473374155
admitted,0.004230711473374155
dopamine,0.004230711473374155
tca,0.004230711473374155
simultaneous,0.004230711473374155
microsined,0.004230711473374155
microangiopathic,0.004230711473374155
mianserine,0.004230711473374155
miami,0.004230711473374155
methylprednisolone,0.004230711473374155
meter,0.004230711473374155
metastases,0.004230711473374155
mesenteric,0.004230711473374155
mental,0.004230711473374155
setons,0.004230711473374155
anal,0.004230711473374155
anaemia,0.004230711473374155
4n,0.004230711473374155
incapacity,0.004230711473374155
molecule,0.004230711473374155
mole,0.004230711473374155
mobilization,0.004230711473374155
470,0.004230711473374155
40ml,0.004230711473374155
4000,0.004230711473374155
cytoreductive,0.004230711473374155
cytomegalovirus,0.004230711473374155
cytologic,0.004230711473374155
cystic,0.004230711473374155
thrombopoietin,0.004230711473374155
thrombocythemia,0.004230711473374155
thiotepa,0.004230711473374155
theorical,0.004230711473374155
theophylline,0.004230711473374155
thalassemias,0.004230711473374155
impeding,0.004230711473374155
immunosuppressed,0.004230711473374155
inability,0.004230711473374155
dated,0.004230711473374155
danlos,0.004230711473374155
edetate,0.004230711473374155
edentate,0.004230711473374155
easy,0.004230711473374155
aminoside,0.004230711473374155
amendment,0.004230711473374155
clairance,0.004230711473374155
cirrhosis,0.004230711473374155
circumstance,0.004230711473374155
circi,0.004230711473374155
monogamous,0.004230711473374155
monobasic,0.004230711473374155
ureteral,0.004230711473374155
unsuitable,0.004230711473374155
unstable,0.004230711473374155
50mmhg,0.004230711473374155
50g,0.004230711473374155
schizophrenia,0.004230711473374155
mirtazapine,0.004230711473374155
myeloblative,0.004230711473374155
mutations,0.004230711473374155
murin,0.004230711473374155
multifocal,0.004230711473374155
goldmann,0.004230711473374155
glycolate,0.004230711473374155
donate,0.004230711473374155
impossible,0.004230711473374155
implant,0.004230711473374155
anosmia,0.004230711473374155
aneurysms,0.004230711473374155
aneurysm,0.004230711473374155
sampled,0.004230711473374155
nephrostomy,0.004230711473374155
cd40l,0.004230711473374155
cavity,0.004230711473374155
caused,0.004230711473374155
neoplasms,0.004230711473374155
serologic,0.004230711473374155
septal,0.004230711473374155
urologic,0.004230711473374155
dusp,0.004230711473374155
fibrillation,0.004230711473374155
favourable,0.004230711473374155
fanconi,0.004230711473374155
norepinephrine,0.004230711473374155
nomegestrol,0.004230711473374155
idec,0.004230711473374155
ideation,0.004230711473374155
fumarate,0.004230711473374155
h2o,0.004230711473374155
h2,0.004230711473374155
guideline,0.004230711473374155
guardian,0.004230711473374155
neck,0.004230711473374155
checking,0.004230711473374155
cfu,0.004230711473374155
cf,0.004230711473374155
cerebrospinal,0.004230711473374155
sat02,0.004230711473374155
antibacterials,0.004230711473374155
t1,0.004230711473374155
syphilis,0.004230711473374155
synechiae,0.004230711473374155
symptothermal,0.004230711473374155
roster,0.004230711473374155
ropinirole,0.004230711473374155
roactemra,0.004230711473374155
expectancy,0.004230711473374155
excipient,0.004230711473374155
exchanges,0.004230711473374155
3rd,0.004230711473374155
375,0.004230711473374155
3000,0.004230711473374155
2nd,0.004230711473374155
nucleocapsid,0.004230711473374155
nsaids,0.004230711473374155
nicolas,0.004230711473374155
neuroimaging,0.004230711473374155
neurogenic,0.004230711473374155
s0,0.004230711473374155
rt,0.004230711473374155
interpretation,0.004230711473374155
cotrimoxazole,0.004230711473374155
costimulation,0.004230711473374155
correct,0.004230711473374155
insult,0.004230711473374155
inv,0.004230711473374155
contraceptionassociated,0.004230711473374155
continuously,0.004230711473374155
constitutional,0.004230711473374155
intolerant,0.004230711473374155
t2,0.004230711473374155
oxymeter,0.004230711473374155
oxide,0.004230711473374155
representative,0.004230711473374155
264,0.004230711473374155
causative,0.004230711473374155
catherization,0.004230711473374155
carriers,0.004230711473374155
carcinomas,0.004230711473374155
capsular,0.004230711473374155
caps,0.004230711473374155
reversible,0.004230711473374155
restriction,0.004230711473374155
researchers,0.004230711473374155
opportunistic,0.004230711473374155
opacities,0.004230711473374155
nodules,0.004230711473374155
ifn,0.004230711473374155
dependance,0.004230711473374155
calcium,0.004230711473374155
opacification,0.004230711473374155
appear,0.004230711473374155
aphtosis,0.004230711473374155
aortic,0.004230711473374155
antivirals,0.004230711473374155
antimalarial,0.004230711473374155
antiherpetic,0.004230711473374155
parasitic,0.004230711473374155
pap,0.004230711473374155
pao,0.004230711473374155
paco2,0.004230711473374155
pac02,0.004230711473374155
ozurdex,0.004230711473374155
ascent,0.004230711473374155
artpo,0.004230711473374155
arginine,0.004230711473374155
ards,0.004230711473374155
representant,0.004230711473374155
remained,0.004230711473374155
reliable,0.004230711473374155
calendar,0.004230711473374155
homeless,0.004230711473374155
historically,0.004230711473374155
histidine,0.004230711473374155
abetimus,0.004230711473374155
98,0.004230711473374155
97,0.004230711473374155
96h,0.004230711473374155
8g,0.004230711473374155
depleting,0.004230711473374155
treatment,0.004230711473374155
tonometry,0.004230711473374155
tizanidine,0.004230711473374155
hypoxia,0.004230711473374155
hrct,0.004230711473374155
brother,0.004230711473374155
parental,0.004230711473374155
pathways,0.004230711473374155
pathologies,0.004230711473374155
patches,0.004230711473374155
parvovirus,0.004230711473374155
paroxysmal,0.004230711473374155
parenterally,0.004230711473374155
refrain,0.004230711473374155
refers,0.004230711473374155
rectum,0.004230711473374155
recist,0.004230711473374155
reaching,0.004230711473374155
pills,0.004230711473374155
phenytoin,0.004230711473374155
phenylephrine,0.004230711473374155
exception,0.004230711473374155
excepted,0.004230711473374155
excellent,0.004230711473374155
examples,0.004230711473374155
empirically,0.004230711473374155
embolism,0.004230711473374155
ehlers,0.004230711473374155
ef,0.004230711473374155
dexamethasone,0.004230711473374155
designees,0.004230711473374155
bmdw,0.004230711473374155
blockers,0.004230711473374155
atherosclerosis,0.004230711473374155
atelectasis,0.004230711473374155
assignee,0.004230711473374155
asplenia,0.004230711473374155
erythropoietin,0.004230711473374155
epinephrine,0.004230711473374155
express,0.004230711473374155
expose,0.004230711473374155
expired,0.004230711473374155
expertise,0.004230711473374155
persistant,0.004230711473374155
perinephric,0.004230711473374155
pericardial,0.004230711473374155
peep,0.004230711473374155
vasectomized,0.004230711473374155
valves,0.004230711473374155
ranieri,0.004230711473374155
pose,0.004230711473374155
porphyria,0.004230711473374155
polysorbate,0.004230711473374155
polycythemia,0.004230711473374155
poloxamer,0.004230711473374155
pneumocystis,0.004230711473374155
plasmatic,0.004230711473374155
breakage,0.004230711473374155
brca,0.004230711473374155
brain,0.004230711473374155
bradycardia,0.004230711473374155
bortezomib,0.004230711473374155
book,0.004230711473374155
5q,0.004230711473374155
5mm,0.004230711473374155
directed,0.004230711473374155
dipropionate,0.004230711473374155
diffusion,0.004230711473374155
dibasic,0.004230711473374155
hbc,0.004230711473374155
diabetic,0.004230711473374155
bile,0.004230711473374155
verbal,0.004230711473374155
vera,0.004230711473374155
vein,0.004230711473374155
vegf,0.004230711473374155
vault,0.004230711473374155
vasopressor,0.004230711473374155
vasopressin,0.004230711473374155
bg9588,0.004230711473374155
beneficiary,0.004230711473374155
pt1,0.004230711473374155
psychosis,0.004230711473374155
psychiatrist,0.004230711473374155
behaviour,0.004230711473374155
probenecid,0.004230711473374155
prisoners,0.004230711473374155
priority,0.004230711473374155
premenopausal,0.004230711473374155
predisposition,0.004230711473374155
bipolar,0.004230711473374155
tuberculin,0.004230711473374155
88,0.004230711473374155
7q,0.004230711473374155
60mmhg,0.004230711473374155
1x109,0.004230711473374155
25mmhg,0.004230711473374155
encephalopathy,0.004230711473374155
etonogestrel,0.004230711473374155
estrogenic,0.004230711473374155
esomeprazole,0.004230711473374155
enterocystoplasty,0.004230711473374155
endotype,0.004230711473374155
endoscope,0.004230711473374155
endocarditis,0.004230711473374155
endocan,0.004230711473374155
000,0.004230711473374155
vii,0.004230711473374155
biggest,0.004230711473374155
rabbit,0.004230711473374155
quinolones,0.004230711473374155
vulnerable,0.004230711473374155
tutelle,0.004230711473374155
turners,0.004230711473374155
tumoral,0.004230711473374155
behcet,0.004230711473374155
protected,0.004230711473374155
barnich,0.004230711473374155
whevener,0.004230711473374155
wcbp,0.004230711473374155
water,0.004230711473374155
188,0.004230711473374155
diverticulitis,0.004230711473374155
disturbances,0.004230711473374155
distress,0.004230711473374155
distearate,0.004230711473374155
dissection,0.004230711473374155
enterobacteriaceae,0.0036507568761492233
epi,0.0036507568761492233
vh,0.0036507568761492233
200,0.0036507568761492233
keratitis,0.0036507568761492233
l2,0.0036507568761492233
lactate,0.0036507568761492233
isoniazid,0.0036507568761492233
joints,0.0036507568761492233
kaposis,0.0036507568761492233
adjustment,0.0036507568761492233
febrile,0.0036507568761492233
fev1,0.0036507568761492233
uti,0.0036507568761492233
blocks,0.0036507568761492233
bowel,0.0036507568761492233
pleural,0.0036507568761492233
ptt,0.0036507568761492233
pulse,0.0036507568761492233
precluding,0.0036507568761492233
periodic,0.0036507568761492233
phenotype,0.0036507568761492233
apply,0.0036507568761492233
fields,0.0036507568761492233
film,0.0036507568761492233
expressed,0.0036507568761492233
extreme,0.0036507568761492233
familial,0.0036507568761492233
fatigue,0.0036507568761492233
administrated,0.0036507568761492233
confirmation,0.0036507568761492233
conseil,0.0036507568761492233
considers,0.0036507568761492233
latest,0.0036507568761492233
stratum,0.0036507568761492233
study,0.0036507568761492233
started,0.0036507568761492233
complication,0.0036507568761492233
cancers,0.0036507568761492233
regional,0.0036507568761492233
glucocorticoid,0.0036507568761492233
typing,0.0036507568761492233
ulcerated,0.0036507568761492233
ulceration,0.0036507568761492233
unconsciousness,0.0036507568761492233
fulfilled,0.0036507568761492233
fluids,0.0036507568761492233
fluorescein,0.0036507568761492233
dysfunction,0.0036507568761492233
receptor,0.0036507568761492233
replication,0.0036507568761492233
pains,0.0036507568761492233
pancreatitis,0.0036507568761492233
anticoagulants,0.0036507568761492233
antinuclear,0.0036507568761492233
aseptic,0.0036507568761492233
refusal,0.0036507568761492233
regardless,0.0036507568761492233
participated,0.0036507568761492233
participating,0.0036507568761492233
pcra,0.0036507568761492233
brutal,0.0036507568761492233
caecum,0.0036507568761492233
adequately,0.0036507568761492233
adhesive,0.0036507568761492233
susceptible,0.0036507568761492233
sustaining,0.0036507568761492233
swab,0.0036507568761492233
interview,0.0036507568761492233
intraocular,0.0036507568761492233
contained,0.0036507568761492233
intercurrent,0.0036507568761492233
inspired,0.0036507568761492233
ac,0.0036507568761492233
accepted,0.0036507568761492233
resection,0.0036507568761492233
7mg,0.0036507568761492233
haemoglobin,0.0036507568761492233
distance,0.0036507568761492233
guidelines,0.0036507568761492233
haematological,0.0036507568761492233
gadolinium,0.0036507568761492233
gel,0.0036507568761492233
glaucoma,0.0036507568761492233
repair,0.0036507568761492233
obstructive,0.0036507568761492233
cataract,0.0036507568761492233
categories,0.0036507568761492233
occlusive,0.0036507568761492233
oedema,0.0036507568761492233
oesogastric,0.0036507568761492233
rifampicin,0.0036507568761492233
apparent,0.0036507568761492233
apparition,0.0036507568761492233
oncolytic,0.0036507568761492233
optional,0.0036507568761492233
sole,0.0036507568761492233
sonography,0.0036507568761492233
sp02,0.0036507568761492233
species,0.0036507568761492233
specifically,0.0036507568761492233
lowest,0.0036507568761492233
lvef,0.0036507568761492233
maintained,0.0036507568761492233
ss,0.0036507568761492233
mdrd,0.0036507568761492233
combine,0.0036507568761492233
transverse,0.0036507568761492233
treating,0.0036507568761492233
troponin,0.0036507568761492233
trv,0.0036507568761492233
depressive,0.0036507568761492233
derivatives,0.0036507568761492233
desire,0.0036507568761492233
discussed,0.0036507568761492233
healthcare,0.0036507568761492233
hematologic,0.0036507568761492233
reticulocytes,0.0036507568761492233
n1,0.0036507568761492233
nelarabine,0.0036507568761492233
risks,0.0036507568761492233
routine,0.0036507568761492233
saliva,0.0036507568761492233
normalized,0.0036507568761492233
neoplasia,0.0036507568761492233
nerve,0.0036507568761492233
neuro,0.0036507568761492233
combining,0.0036507568761492233
tachycardia,0.0036507568761492233
inferior,0.0036507568761492233
crossed,0.0036507568761492233
crt,0.0036507568761492233
inactivity,0.0036507568761492233
inefficacy,0.0036507568761492233
classical,0.0036507568761492233
classified,0.0036507568761492233
cm,0.0036507568761492233
segments,0.0036507568761492233
selective,0.0036507568761492233
mucosa,0.0036507568761492233
multidisciplinary,0.0036507568761492233
myelitis,0.0036507568761492233
ckd,0.0036507568761492233
minimize,0.0036507568761492233
angio,0.0036507568761492233
cessation,0.0036507568761492233
ambulatory,0.0036507568761492233
sharing,0.0036507568761492233
short,0.0036507568761492233
shortening,0.0036507568761492233
showing,0.0036507568761492233
shows,0.0036507568761492233
significantly,0.0036507568761492233
simple,0.0036507568761492233
household,0.0036507568761492233
transcriptomic,0.0036507568761492233
transformed,0.0036507568761492233
meetings,0.0036507568761492233
sirolimus,0.0036507568761492233
alemtuzumab,0.0036507568761492233
allogenic,0.0036507568761492233
ileocolonoscopy,0.0036507568761492233
immediately,0.0036507568761492233
deep,0.0036507568761492233
serologies,0.0036507568761492233
alternatively,0.0036507568761492233
02,0.0036507568761492233
proteasome,0.0036507568761492233
avoiding,0.0036507568761492233
betamethasone,0.0036507568761492233
program,0.0036507568761492233
properly,0.0036507568761492233
properties,0.0036507568761492233
premedication,0.0036507568761492233
eu,0.0036507568761492233
enhancement,0.0036507568761492233
enrol,0.0036507568761492233
asthma,0.0036507568761492233
30g,0.0036507568761492233
38c,0.0036507568761492233
excessive,0.0036507568761492233
electrophoresis,0.0036507568761492233
example,0.0036507568761492233
vasoconstrictor,0.0036507568761492233
episodes,0.0036507568761492233
ending,0.0036507568761492233
2000,0.0036507568761492233
website,0.0036507568761492233
20mg,0.0036507568761492233
vasopressors,0.003200909142076519
eltrombopag,0.003200909142076519
experienced,0.003200909142076519
radiological,0.003200909142076519
ensuring,0.003200909142076519
enroll,0.003200909142076519
established,0.003200909142076519
essential,0.003200909142076519
avoid,0.003200909142076519
degree,0.003200909142076519
threshold,0.003200909142076519
tested,0.003200909142076519
allocated,0.003200909142076519
alkaline,0.003200909142076519
air,0.003200909142076519
medullar,0.003200909142076519
hydrocortisone,0.003200909142076519
abnormality,0.003200909142076519
ab,0.003200909142076519
sight,0.003200909142076519
microns,0.003200909142076519
myocarditis,0.003200909142076519
checkpoint,0.003200909142076519
saturation,0.003200909142076519
ciprofloxacin,0.003200909142076519
monitored,0.003200909142076519
murine,0.003200909142076519
serological,0.003200909142076519
targeting,0.003200909142076519
independently,0.003200909142076519
targeted,0.003200909142076519
software,0.003200909142076519
mammography,0.003200909142076519
make,0.003200909142076519
transmission,0.003200909142076519
cd4,0.003200909142076519
cd20,0.003200909142076519
observational,0.003200909142076519
room,0.003200909142076519
scheduled,0.003200909142076519
nasal,0.003200909142076519
retinopathy,0.003200909142076519
responding,0.003200909142076519
direct,0.003200909142076519
determination,0.003200909142076519
dependency,0.003200909142076519
colonized,0.003200909142076519
match,0.003200909142076519
alloimmunization,0.003200909142076519
longer,0.003200909142076519
special,0.003200909142076519
option,0.003200909142076519
apn,0.003200909142076519
rifaximin,0.003200909142076519
rheumatoid,0.003200909142076519
cases,0.003200909142076519
relationship,0.003200909142076519
graaph,0.003200909142076519
haut,0.003200909142076519
tubes,0.003200909142076519
outpatient,0.003200909142076519
osteonecrosis,0.003200909142076519
creatininuria,0.003200909142076519
intervention,0.003200909142076519
contact,0.003200909142076519
adenocarcinoma,0.003200909142076519
antidepressant,0.003200909142076519
pain,0.003200909142076519
replaced,0.003200909142076519
fludrocortisone,0.003200909142076519
drop,0.003200909142076519
glucocorticoids,0.003200909142076519
registry,0.003200909142076519
load,0.003200909142076519
lines,0.003200909142076519
stated,0.003200909142076519
superior,0.003200909142076519
summary,0.003200909142076519
conjugate,0.003200909142076519
stratified,0.003200909142076519
extensive,0.003200909142076519
5l,0.003200909142076519
earlier,0.003200909142076519
arthritis,0.003200909142076519
pharmacodynamics,0.003200909142076519
persons,0.003200909142076519
recovery,0.003200909142076519
birads,0.003200909142076519
biology,0.003200909142076519
pt,0.003200909142076519
plasmapheresis,0.003200909142076519
physical,0.003200909142076519
phosphatase,0.003200909142076519
features,0.003200909142076519
surgical,0.003200909142076519
joint,0.003200909142076519
l1,0.003200909142076519
ktr,0.003200909142076519
keytruda,0.003200909142076519
www,0.002833356780767722
01,0.002833356780767722
180,0.002833356780767722
proposed,0.002833356780767722
protein,0.002833356780767722
beta,0.002833356780767722
better,0.002833356780767722
estimated,0.002833356780767722
kidney,0.002833356780767722
la,0.002833356780767722
lower,0.002833356780767722
lupus,0.002833356780767722
stroke,0.002833356780767722
like,0.002833356780767722
stay,0.002833356780767722
computed,0.002833356780767722
law,0.002833356780767722
maximum,0.002833356780767722
mechanical,0.002833356780767722
achieved,0.002833356780767722
allograft,0.002833356780767722
sledai,0.002833356780767722
conventional,0.002833356780767722
addition,0.002833356780767722
sant,0.002833356780767722
thymoglobulin,0.002833356780767722
cycle,0.002833356780767722
damage,0.002833356780767722
immediate,0.002833356780767722
improvement,0.002833356780767722
define,0.002833356780767722
silent,0.002833356780767722
mesylate,0.002833356780767722
analysed,0.002833356780767722
aa,0.002833356780767722
coherence,0.002833356780767722
medicine,0.002833356780767722
terminology,0.002833356780767722
induced,0.002833356780767722
criterion,0.002833356780767722
complementary,0.002833356780767722
class,0.002833356780767722
authority,0.002833356780767722
attributed,0.002833356780767722
rapidly,0.002833356780767722
rapid,0.002833356780767722
platelets,0.002833356780767722
biomedical,0.002833356780767722
reactive,0.002833356780767722
phenotypic,0.002833356780767722
biomarkers,0.002833356780767722
especially,0.002833356780767722
virological,0.002833356780767722
106,0.002833356780767722
elderly,0.002833356780767722
expected,0.002833356780767722
practice,0.002833356780767722
possible,0.002833356780767722
overlap,0.002833356780767722
particular,0.002833356780767722
charge,0.002833356780767722
niu,0.002833356780767722
responsible,0.002833356780767722
optical,0.002833356780767722
cerebral,0.002833356780767722
deterioration,0.002833356780767722
mismatch,0.002833356780767722
selena,0.002833356780767722
sarcoma,0.002833356780767722
mud,0.002833356780767722
toxicities,0.002833356780767722
http,0.002833356780767722
tomography,0.002833356780767722
respond,0.002833356780767722
80mg,0.002833356780767722
gr,0.002833356780767722
eyes,0.002833356780767722
area,0.002833356780767722
person,0.002833356780767722
candidate,0.002833356780767722
require,0.002833356780767722
participant,0.002833356780767722
responders,0.002833356780767722
65,0.002833356780767722
twice,0.002833356780767722
diseases,0.002833356780767722
2012,0.00252259568721313
effects,0.00252259568721313
interaction,0.00252259568721313
mds,0.00252259568721313
evaluation,0.00252259568721313
endpoints,0.00252259568721313
plan,0.00252259568721313
points,0.00252259568721313
factor,0.00252259568721313
follows,0.00252259568721313
loss,0.00252259568721313
low,0.00252259568721313
iron,0.00252259568721313
support,0.00252259568721313
kaposi,0.00252259568721313
late,0.00252259568721313
starting,0.00252259568721313
line,0.00252259568721313
cause,0.00252259568721313
taken,0.00252259568721313
2016,0.00252259568721313
2013,0.00252259568721313
exposed,0.00252259568721313
exposure,0.00252259568721313
point,0.00252259568721313
family,0.00252259568721313
reference,0.00252259568721313
pembrolizumab,0.00252259568721313
flow,0.00252259568721313
camostat,0.00252259568721313
reduce,0.00252259568721313
report,0.00252259568721313
partial,0.00252259568721313
overload,0.00252259568721313
neutrophils,0.00252259568721313
des,0.00252259568721313
minimal,0.00252259568721313
chamber,0.00252259568721313
decrease,0.00252259568721313
therapeutic,0.00252259568721313
infusions,0.00252259568721313
sites,0.00252259568721313
medium,0.00252259568721313
medications,0.00252259568721313
higher,0.00252259568721313
delayed,0.00252259568721313
https,0.00252259568721313
mixed,0.00252259568721313
review,0.00252259568721313
centre,0.00252259568721313
onset,0.00252259568721313
parameters,0.00252259568721313
percentage,0.00252259568721313
perform,0.00252259568721313
pr,0.00252259568721313
adapted,0.002253402183542791
survival,0.002253402183542791
et,0.002253402183542791
step,0.002253402183542791
event,0.002253402183542791
main,0.002253402183542791
date,0.002253402183542791
information,0.002253402183542791
infections,0.002253402183542791
immune,0.002253402183542791
amplification,0.002253402183542791
includes,0.002253402183542791
analysis,0.002253402183542791
order,0.002253402183542791
ongoing,0.002253402183542791
characteristics,0.002253402183542791
observed,0.002253402183542791
toxicity,0.002253402183542791
tnf,0.002253402183542791
samples,0.002253402183542791
outcome,0.002253402183542791
phase,0.002253402183542791
followed,0.002253402183542791
france,0.002253402183542791
overall,0.002253402183542791
probability,0.002253402183542791
plasma,0.002253402183542791
prca,0.002253402183542791
24,0.002253402183542791
